Latest Headlines
-
Cytiva And Pall Life Sciences Complete Integration To Create A Global Innovation And Solutions Leader In Biotechnology
5/23/2023
Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. With nearly 16 000 associates in 40 countries, and more than 300 years’ heritage of trusted expertise, the new Cytiva supports customers in solving major biotechnology challenges and plays a critical role in advancing and accelerating therapeutics for the benefit of patients everywhere.
-
Next-Generation EV Separation: Izon Science And Agarose Bead Technologies Collaborate To Enhance Clinical Applications For Extracellular Vesicles
5/19/2023
Recent studies have revealed that extracellular vesicles (EVs) play an important role in intercellular communication; however, their specific role(s) in immune response and cellular signaling still remain ill-defined.
-
Ajinomoto Bio-Pharma Services Announces US Facility Leadership Changes
5/18/2023
Learn how leadership changes at Aji Bio-Pharma's site in San Diego will bring integral expertise to the company as it continues to expand its capacity and service offerings.
-
AGC Biologics Launches BravoAAV™ And ProntoLVV™ Platforms
5/18/2023
The new Biologics AAV and LVV platforms offer fast, efficient, and reproducible clinical and commercial GMP production and release and are supported by proprietary process and capsid-specific platform methods.
-
Eppendorf Simplifies Bioprocess Data Acquisition With The Launch Of The Bioprocess Autosampler
5/15/2023
Being well informed on what is going on inside the bioreactor is indispensable for optimizing yield and quality of the desired end product and ensuring it is formed in a time and cost-saving manner. Analyzing relevant parameters like the cells’ status, product concentration, and medium composition usually requires taking a sample from the bioreactor. Eppendorf, a leading life science company, introduces the Bioprocess Autosampler. It facilitates sampling 24/7 in short and regular intervals and like this gaining complete datasets. -
Eppendorf Group Inaugurates New Distribution Center In Connecticut
5/10/2023
The opening of Eppendorf Group’s new distribution center in Enfield demonstrates its ambitions and its strong commitment to the market region of the Americas.
-
FIMEA Renews Nanoform’s GMP License And Nanoform Starts Clinical API Manufacturing Of A Blockbuster Medicine Candidate
5/9/2023
Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, are delighted to announce that FIMEA (Finnish Medicines Agency) has completed another successful general good manufacturing practices (GMP) inspection of Nanoform.